Green tea epigallocatechin-3-gallate inhibits microsomal prostaglandin E2 synthase-1

Biochemical and Biophysical Research Communications

Volumn 388, Issue 2, 2009, Pages 350-354

  Koeberle, Andreas ^a   Bauer, Julia ^a   Verhoff, Moritz ^a   Hoffmann, Marika ^b   Northoff, Hinnak ^c   Werz, Oliver ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b ZAFES   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Camellia sinensis; Cyclooxygenase; Epigallocatechin 3 gallate; Microsomal prostaglandin E2 synthase 1; Prostaglandin

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; 6 OXOPROSTAGLANDIN F1 ALPHA; ANTINEOPLASTIC AGENT; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOSOLIC PHOSPHOLIPASE A2; EPIGALLOCATECHIN GALLATE; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E SYNTHASE 1; PROSTAGLANDIN E2; PROSTANOID;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG TARGETING; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LUNG ADENOCARCINOMA; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; TEA;

ANTICARCINOGENIC AGENTS; CAMELLIA SINENSIS; CATECHIN; DINOPROSTONE; ENZYME INHIBITORS; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; MICROSOMES; PROSTAGLANDIN H2;

CAMELLIA SINENSIS;

EID: 69249216367     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.08.005     Document Type: Article

References (37)

1. Khan N., and Mukhtar H. Multitargeted therapy of cancer by green tea polyphenols. Cancer Lett. 269 (2008) 269-280
2. Liang Y.C., Lin-Shiau S.Y., Chen C.F., and Lin J.K. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate. J. Cell. Biochem. 75 (1999) 1-12
3. Lin Y.L., and Lin J.K. (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB. Mol. Pharmacol. 52 (1997) 465-472
4. Dong Z., Ma W., Huang C., and Yang C.S. Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins. Cancer Res. 57 (1997) 4414-4419
5. Nam S., Smith D.M., and Dou Q.P. Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo. J. Biol. Chem. 276 (2001) 13322-13330
6. Khan N., Afaq F., Saleem M., Ahmad N., and Mukhtar H. Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res. 66 (2006) 2500-2505
7. Hong J., Smith T.J., Ho C.T., August D.A., and Yang C.S. Effects of purified green and black tea polyphenols on cyclooxygenase- and lipoxygenase-dependent metabolism of arachidonic acid in human colon mucosa and colon tumor tissues. Biochem. Pharmacol. 62 (2001) 1175-1183
8. Lu J., Gosslau A., Liu A.Y., and Chen K.Y. PCR differential display-based identification of regulator of G protein signaling 10 as the target gene in human colon cancer cells induced by black tea polyphenol theaflavin monogallate. Eur. J. Pharmacol. 601 (2008) 66-72
9. Ahmed S., Rahman A., Hasnain A., Lalonde M., Goldberg V.M., and Haqqi T.M. Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1 beta-induced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrocytes. Free Radic. Biol. Med. 33 (2002) 1097-1105
10. Hussain T., Gupta S., Adhami V.M., and Mukhtar H. Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells. Int. J. Cancer 113 (2005) 660-669
11. Porath D., Riegger C., Drewe J., and Schwager J. Epigallocatechin-3-gallate impairs chemokine production in human colon epithelial cell lines. J. Pharmacol. Exp. Ther. 315 (2005) 1172-1180
12. Peng G., Dixon D.A., Muga S.J., Smith T.J., and Wargovich M.J. Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits cyclooxygenase-2 expression in colon carcinogenesis. Mol. Carcinog. 45 (2006) 309-319
13. Murakami M., Naraba H., Tanioka T., Semmyo N., Nakatani Y., Kojima F., Ikeda T., Fueki M., Ueno A., Oh S., and Kudo I. Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J. Biol. Chem. 275 (2000) 32783-32792
14. Thoren S., and Jakobsson P.J. Coordinate up- and down-regulation of glutathione-dependent prostaglandin E synthase and cyclooxygenase-2 in A549 cells. Inhibition by NS-398 and leukotriene C4. Eur. J. Biochem. 267 (2000) 6428-6434
15. Park J.Y., Pillinger M.H., and Abramson S.B. Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases. Clin. Immunol. 119 (2006) 229-240
16. Tanioka T., Nakatani Y., Semmyo N., Murakami M., and Kudo I. Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J. Biol. Chem. 275 (2000) 32775-32782
17. Jania L.A., Chandrasekharan S., Backlund M.G., Foley N.A., Snouwaert J., Wang I.M., Clark P., Audoly L.P., and Koller B.H. Microsomal prostaglandin E synthase-2 is not essential for in vivo prostaglandin E2 biosynthesis. Prostaglandins Other Lipid Mediat. 88 (2009) 73-81
18. Sugimoto Y., and Narumiya S. Prostaglandin E receptors. J. Biol. Chem. 282 (2007) 11613-11617
19. Wang D., and Dubois R.N. Prostaglandins and cancer. Gut 55 (2006) 115-122
20. de Carvalho M.S., McCormack F.X., and Leslie C.C. The 85-kDa, arachidonic acid-specific phospholipase A2 is expressed as an activated phosphoprotein in Sf9 cells. Arch. Biochem. Biophys. 306 (1993) 534-540
21. Knospe J., Steinhilber D., Herrmann T., and Roth H.J. Picomole determination of 2,4-dimethoxyanilides of prostaglandins by high-performance liquid chromatography with electrochemical detection. J. Chromatogr. 442 (1988) 444-450
22. Koeberle A., Siemoneit U., Buehring U., Northoff H., Laufer S., Albrecht W., and Werz O. Licofelone suppresses prostaglandin E2 formation by interference with the inducible microsomal prostaglandin E2 synthase-1. J. Pharmacol. Exp. Ther. 326 (2008) 975-982
23. Koeberle A., Pollastro F., Northoff H., and Werz O. Myrtucommulone, a natural acylphloroglucinol, inhibits microsomal prostaglandin E2 synthase-1. Br. J. Pharmacol. 156 (2009) 952-961
24. Samuelsson B., Morgenstern R., and Jakobsson P.J. Membrane prostaglandin E synthase-1: a novel therapeutic target. Pharmacol. Rev. 59 (2007) 207-224
25. Lichtenbergova L., Yoon E.T., and Cho W. Membrane penetration of cytosolic phospholipase A2 is necessary for its interfacial catalysis and arachidonate specificity. Biochemistry 37 (1998) 14128-14136
26. Jakobsson P.J., Thoren S., Morgenstern R., and Samuelsson B. Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc. Natl. Acad. Sci. USA 96 (1999) 7220-7225
27. Ghomashchi F., Stewart A., Hefner Y., Ramanadham S., Turk J., Leslie C.C., and Gelb M.H. A pyrrolidine-based specific inhibitor of cytosolic phospholipase A(2)alpha blocks arachidonic acid release in a variety of mammalian cells. Biochim. Biophys. Acta 1513 (2001) 160-166
28. Seeram N.P., Zhang Y., and Nair M.G. Inhibition of proliferation of human cancer cells and cyclooxygenase enzymes by anthocyanidins and catechins. Nutr. Cancer 46 (2003) 101-106
29. Cote B., Boulet L., Brideau C., Claveau D., Ethier D., Frenette R., Gagnon M., Giroux A., Guay J., Guiral S., Mancini J., Martins E., Masse F., Methot N., Riendeau D., Rubin J., Xu D., Yu H., Ducharme Y., and Friesen R.W. Substituted phenanthrene imidazoles as potent, selective, and orally active mPGES-1 inhibitors. Bioorg. Med. Chem. Lett. 17 (2007) 6816-6820
30. Nakanishi M., Montrose D.C., Clark P., Nambiar P.R., Belinsky G.S., Claffey K.P., Xu D., and Rosenberg D.W. Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis. Cancer Res. 68 (2008) 3251-3259
31. Wang M., Song W.L., Cheng Y., and Fitzgerald G.A. Microsomal prostaglandin E synthase-1 inhibition in cardiovascular inflammatory disease. J. Intern. Med. 263 (2008) 500-505
32. Chow H.H., Hakim I.A., Vining D.R., Crowell J.A., Ranger-Moore J., Chew W.M., Celaya C.A., Rodney S.R., Hara Y., and Alberts D.S. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals. Clin. Cancer Res. 11 (2005) 4627-4633
33. Lu J., Ho C.T., Ghai G., and Chen K.Y. Differential effects of theaflavin monogallates on cell growth, apoptosis, and Cox-2 gene expression in cancerous versus normal cells. Cancer Res. 60 (2000) 6465-6471
34. Kundu J.K., Na H.K., Chun K.S., Kim Y.K., Lee S.J., Lee S.S., Lee O.S., Sim Y.C., and Surh Y.J. Inhibition of phorbol ester-induced COX-2 expression by epigallocatechin gallate in mouse skin and cultured human mammary epithelial cells. J. Nutr. 133 (2003) 3805S-3810S
35. Shimizu M., Deguchi A., Joe A.K., McKoy J.F., Moriwaki H., and Weinstein I.B. EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells. J. Exp. Ther. Oncol. 5 (2005) 69-78
36. Katiyar S.K., Matsui M.S., Elmets C.A., and Mukhtar H. Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea reduces UVB-induced inflammatory responses and infiltration of leukocytes in human skin. Photochem. Photobiol. 69 (1999) 148-153
37. Mizugaki M., Ishizawa F., Yamazaki T., and Hishinuma T. Epigallocatechin gallate increase the prostacyclin production of bovine aortic endothelial cells. Prostaglandins Other Lipid Mediat. 62 (2000) 157-164